Innovation Hub
The latest breakthroughs, technologies, and resources across every stage in the drug development lifecycle.
Button Text
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Antibodies
Protein Sciences
Cell Culture & Characterization
In Vitro Assays
Biointron
Blog
What the New U.S.-UK Pharmaceuticals Deal Really Means for Pricing, Access, and Global Market Dynamics
December 5, 2025
Read blog
Market Access
No items found.
Blog
AI's Quiet Revolution in the Pharma Supply Chain with Chris Petersen, Scientist.com
December 5, 2025
Read blog
Chemistry, Manufacturing & Controls
No items found.
Blog
Advancing Sarcopenia Research: CUHK Lab Unveils Early NMJ Deficits in Aging with Aurora Scientific's 1200A
December 1, 2025
Read blog
Disease Models
Aurora Scientific, Inc.
Biomarkers
Cell Culture & Characterization
Protein Sciences
DNA & RNA
Precision for Medicine
Blog
Faster Insights or Faster Fail? How to Avoid the Misuse of Real-World Data when Using AI
November 12, 2025
Read blog
Real-World Data (RWD)
Panalgo, LLC
Blog
Building Bridges in Muscle Research: The Story Behind AMB's Innovative Approach and Partnership with Aurora Scientific
November 5, 2025
Read blog
No items found.
Aurora Scientific, Inc.
Cell Culture & Characterization
In Vitro Assays
Antibodies
Ignyte Bio
Blog
Using Real-World Data to Understand the Impact of IRA Policy on Patient Outcomes and Health Equity
October 22, 2025
Read blog
Real-World Data (RWD)
Panalgo, LLC
Blog
When the Evidence Fails the Drug: Is the Role of Study Design Being Overlooked During Discovery?
October 16, 2025
Read blog
Health Economics & Outcomes Research (HEOR)
Adigens Health
Blog
Bringing Clarity and Efficiency to Early Drug Screening: How Chemical Protein Stability Assays (CPSA) Help Drive Decisions at the Hit/Lead Discovery Stage
October 15, 2025
Read blog
Protein Sciences
Discovery Chemistry
In Vitro Assays
Medicines Discovery Catapult
Cell Culture & Characterization
Disease Models
In Vitro Assays
Toxicology
PromoCell
Antibodies
Protein Sciences
Cell Culture & Characterization
In Vitro Assays
Biointron
Pharmacology
Disease Models
Catherine Robin-Jagerschmidt
Didier Merciris
Vincent Dumont
Novalix
Scientist.com
Bioimaging
Disease Models
Emmanuelle Canet-Soulas
Pierre Sicard
Kristyna Neffeova
FUJIFILM VisualSonics Inc.
No items found.
Pharmacology
Disease Models
Clinical Trials
Simon Jiang
Luke Piggott
Shanghai LIDE Biotech Co., Ltd. (LIDE Biotech)
Scientist.com
Pharmacology
Cell Culture & Characterization
Semra Sahin
Matthew Mandeville
BrainXell Inc.
Scientist.com
Disease Models
HBS
Pharmacology
Cathie G. Miller
Pauline Mespoulhé
BioIVT
France Tissue Bank
Scientist.com
Podcast
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
July 13, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)
Podcast
Integrated Evidence Delivery: Why HEOR belongs at the heart of the Modern CRO
February 23, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Podcast
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies
October 6, 2025
Read podcast
Health Economics & Outcomes Research (HEOR)
Clinical Trials
.jpg)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.